CuroVax
Yangzhou
About CuroVax
CuroVax researches and focuses on developing and producing vaccines for various diseases. It provides biotechnology and microbiology services to improve the health and medical industry. CuroVax was founded in 2011 and is based in Changzhou City, China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Funding stage: Early Stage Venture
- Last round: Series B (May 2023)
- Website: curovax.net
- Phone: 86-0519-81668935
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Medical
Canonical: https://fsome.com/organization/curovax-2862728 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.